US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

PHVS

Pharvaris NV (PHVS)

Pharvaris NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHVS

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/03	06 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/11/14	06 : 12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/11/14	06 : 10	GlobeNewswire Inc.	Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates	NASDAQ:PHVS	Pharvaris NV
2024/11/12	20 : 50	GlobeNewswire Inc.	Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference	NASDAQ:PHVS	Pharvaris NV
2024/11/01	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/10/25	05 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/10/24	21 : 00	GlobeNewswire Inc.	Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting	NASDAQ:PHVS	Pharvaris NV
2024/10/16	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings	NASDAQ:PHVS	Pharvaris NV
2024/10/15	19 : 50	GlobeNewswire Inc.	Pharvaris to Host Virtual Investor Event on October 23, 2024	NASDAQ:PHVS	Pharvaris NV
2024/10/03	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop	NASDAQ:PHVS	Pharvaris NV
2024/09/25	19 : 50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/23	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/21	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	07 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	07 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/17	05 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 50	GlobeNewswire Inc.	Pharvaris Provides Business Update and Expands Development Program for Deucrictibant	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 49	GlobeNewswire Inc.	Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 48	GlobeNewswire Inc.	Pharvaris Presents Data at the Bradykinin Symposium 2024	NASDAQ:PHVS	Pharvaris NV
2024/08/28	19 : 50	GlobeNewswire Inc.	Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium	NASDAQ:PHVS	Pharvaris NV
2024/08/14	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/08/14	19 : 50	GlobeNewswire Inc.	Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/06/11	19 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/06/11	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Annual Meeting of Shareholders	NASDAQ:PHVS	Pharvaris NV
2024/06/05	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/06/04	19 : 50	GlobeNewswire Inc.	Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses	NASDAQ:PHVS	Pharvaris NV
2024/05/25	06 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/05/23	06 : 54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV

Showing the most relevant articles for your search:NASDAQ:PHVS

1 2 3 4 5 6 7 次へ >>

Bank of America

Health Care Select Sector

Invesco QQQ Trust Series 1

Verizon Communications

US Dollar vs Euro

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約